IBDEI0NP ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23913,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,23913,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,23914,0)
 ;;=G23.8^^92^1104^10
 ;;^UTILITY(U,$J,358.3,23914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23914,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,23914,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,23914,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,23915,0)
 ;;=G30.0^^92^1104^2
 ;;^UTILITY(U,$J,358.3,23915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23915,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,23915,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,23915,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,23916,0)
 ;;=G30.1^^92^1104^3
 ;;^UTILITY(U,$J,358.3,23916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23916,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,23916,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,23916,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,23917,0)
 ;;=B20.^^92^1104^21
 ;;^UTILITY(U,$J,358.3,23917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23917,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,23917,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,23917,2)
 ;;=^5000555^
 ;;^UTILITY(U,$J,358.3,23918,0)
 ;;=G10.^^92^1104^22
 ;;^UTILITY(U,$J,358.3,23918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23918,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,23918,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,23918,2)
 ;;=^5003751^
 ;;^UTILITY(U,$J,358.3,23919,0)
 ;;=G30.8^^92^1104^1
 ;;^UTILITY(U,$J,358.3,23919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23919,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,23919,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,23919,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,23920,0)
 ;;=A81.89^^92^1104^5
 ;;^UTILITY(U,$J,358.3,23920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23920,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,23920,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,23920,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,23921,0)
 ;;=G20.^^92^1104^69
 ;;^UTILITY(U,$J,358.3,23921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23921,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,23921,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,23921,2)
 ;;=^5003770^
 ;;^UTILITY(U,$J,358.3,23922,0)
 ;;=G23.1^^92^1104^73
 ;;^UTILITY(U,$J,358.3,23922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23922,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,23922,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,23922,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,23923,0)
 ;;=F03.91^^92^1104^17
 ;;^UTILITY(U,$J,358.3,23923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23923,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,23923,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,23923,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,23924,0)
 ;;=F03.90^^92^1104^19
 ;;^UTILITY(U,$J,358.3,23924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23924,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,23924,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,23924,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,23925,0)
 ;;=F02.81^^92^1104^40
 ;;^UTILITY(U,$J,358.3,23925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23925,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,23925,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,23925,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,23926,0)
 ;;=F02.80^^92^1104^41
 ;;^UTILITY(U,$J,358.3,23926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23926,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,23926,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,23926,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,23927,0)
 ;;=G31.84^^92^1104^56
 ;;^UTILITY(U,$J,358.3,23927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23927,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ALZHEIMER'S DISEASE
 ;;^UTILITY(U,$J,358.3,23927,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,23927,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,23928,0)
 ;;=F02.81^^92^1104^24
 ;;^UTILITY(U,$J,358.3,23928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23928,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,23928,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,23928,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,23929,0)
 ;;=F02.80^^92^1104^25
 ;;^UTILITY(U,$J,358.3,23929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23929,1,3,0)
 ;;=3^Major Neurocog D/O d/t ANOTHER MED COND w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,23929,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,23929,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,23930,0)
 ;;=G31.84^^92^1104^57
 ;;^UTILITY(U,$J,358.3,23930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23930,1,3,0)
 ;;=3^Mild Neurocog D/O d/t ANOTHER MEDICAL CONDITION
 ;;^UTILITY(U,$J,358.3,23930,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,23930,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,23931,0)
 ;;=A81.01^^92^1104^9
 ;;^UTILITY(U,$J,358.3,23931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23931,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Variant
 ;;^UTILITY(U,$J,358.3,23931,1,4,0)
 ;;=4^A81.01
 ;;^UTILITY(U,$J,358.3,23931,2)
 ;;=^336701
 ;;^UTILITY(U,$J,358.3,23932,0)
 ;;=F05.^^92^1104^13
 ;;^UTILITY(U,$J,358.3,23932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23932,1,3,0)
 ;;=3^Delirium d/t Another Medical Condition
 ;;^UTILITY(U,$J,358.3,23932,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,23932,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,23933,0)
 ;;=F05.^^92^1104^14
 ;;^UTILITY(U,$J,358.3,23933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23933,1,3,0)
 ;;=3^Delirium d/t Multiple Etiologies
 ;;^UTILITY(U,$J,358.3,23933,1,4,0)
 ;;=4^F05.
 ;;^UTILITY(U,$J,358.3,23933,2)
 ;;=^5003052
 ;;^UTILITY(U,$J,358.3,23934,0)
 ;;=R41.0^^92^1104^15
 ;;^UTILITY(U,$J,358.3,23934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23934,1,3,0)
 ;;=3^Delirium,Other Specified
 ;;^UTILITY(U,$J,358.3,23934,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,23934,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,23935,0)
 ;;=R41.0^^92^1104^16
 ;;^UTILITY(U,$J,358.3,23935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23935,1,3,0)
 ;;=3^Delirium,Unspec
 ;;^UTILITY(U,$J,358.3,23935,1,4,0)
 ;;=4^R41.0
 ;;^UTILITY(U,$J,358.3,23935,2)
 ;;=^5019436
 ;;^UTILITY(U,$J,358.3,23936,0)
 ;;=G31.09^^92^1104^20
 ;;^UTILITY(U,$J,358.3,23936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23936,1,3,0)
 ;;=3^Frontotemporal Disease
 ;;^UTILITY(U,$J,358.3,23936,1,4,0)
 ;;=4^G31.09
 ;;^UTILITY(U,$J,358.3,23936,2)
 ;;=^329916
 ;;^UTILITY(U,$J,358.3,23937,0)
 ;;=F02.81^^92^1104^36
 ;;^UTILITY(U,$J,358.3,23937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23937,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,23937,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,23937,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,23938,0)
 ;;=F02.80^^92^1104^37
 ;;^UTILITY(U,$J,358.3,23938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23938,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,23938,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,23938,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,23939,0)
 ;;=F02.81^^92^1104^42
 ;;^UTILITY(U,$J,358.3,23939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23939,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,23939,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,23939,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,23940,0)
 ;;=F02.80^^92^1104^43
 ;;^UTILITY(U,$J,358.3,23940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23940,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob FRONTOTEMP LOBAR DEGEN w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,23940,1,4,0)
 ;;=4^F02.80
